LPTX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 145408 min ago

@ $3.52

Wydano: 8 vas. 2024 @ 21:59

Zwrot: -25.28%

Poprzedni sygnał: vas. 7 - 22:44

Poprzedni sygnał: Kupno

Zwrot: 2.03 %

Live Chart Being Loaded With Signals

Commentary (17 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	375 785
Średni wolumen	307 798
Kapitalizacja rynkowa	100.64M
EPS	$0 ( 2024-05-13 )
Następna data zysków	( $-0.570 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.660
ATR14	$0.0230 (0.87%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-10	Gilead Sciences, Inc.	Sell	0	Common Stock
2024-01-29	Mashiach Nissim	Buy	25 000	Stock Option (Right to Buy)
2024-01-29	Dietz Thomas John	Buy	30 000	Stock Option (Right to Buy)
2024-01-29	Schilsky Richard	Buy	25 000	Stock Option (Right to Buy)
2024-01-29	Granfield Christine	Buy	85 000	Employee Stock Option (Right to Buy)

INSIDER POWER
66.43
Last 95 transactions
Buy: 10 825 606 \| Sell: 1 768 106

Wolumen Korelacja

Długi: 0.14 (neutral)

Krótki: -0.76 (moderate negative)

Signal:(53.092) Neutral

Leap Therapeutics Inc Korelacja

10 Najbardziej pozytywne korelacje
AUR	0.84
MYNA	0.812
ANGO	0.807
RELL	0.806

10 Najbardziej negatywne korelacje
KROS	-0.851
PPH	-0.836
REGN	-0.815

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Leap Therapeutics Inc Korelacja - Waluta/Towar

0.52
( weak )

0.44
( neutral )

0.00
( neutral )

0.61
( weak )

0.29
( neutral )

0.47
( neutral )

Leap Therapeutics Inc Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-427 000 (0.00 %)
EPS:	$-3.98

FY	2023
Przychody:	$0
Zysk brutto:	$-427 000 (0.00 %)
EPS:	$-3.98

FY	2022
Przychody:	$0
Zysk brutto:	$-415 000 (0.00 %)
EPS:	$-4.82

FY	2021
Przychody:	$1.50M
Zysk brutto:	$1.50M (100.00 %)
EPS:	$-0.470

Financial Reports:

No articles found.

Leap Therapeutics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Leap Therapeutics Inc

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Aktualne aktualizacje dla Leap Therapeutics Inc [LPTX]

Upcoming Earnings Alert

Leap Therapeutics Inc Options Data

Calls

Puts